In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos
The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July.
The OpenAI Foundation has committed $100m to help fund a new public health initiative initially focused on hepatitis C.
In a first for consumer wearables, Google has introduced a feature on Pixel Watch and Fitbit Air devices that it says can monitor insulin resistance.
pharmaphorum spoke with Alexander Seyf, CEO of Autolomous, about the future of AI in Australian biotech.
Editor's Picks
